The Polo-Like Kinase 1 (PLK1) Inhibitor NMS-P937 Is Effective in a New Model of Disseminated Primary CD56+ Acute Monoblastic LeukaemiaAlessia Casolaro, Rachele Alzani, Veronica Patton et al.|PLoS ONE|2013Cited by 34
PLK1 expression in AML-NS8 cells and activity of PLK1 inhibitor NMS-937 <i>in vitro</i> and <i>in vivo</i>.Alessia Casolaro, Rachele Alzani, Josée Golay et al.|Figshare|2015Cited by 0